Asset Details
Do you wish to reserve the book?
Lev Pharmaceuticals to Present at C.E. Unterberg, Towbin Life Sciences Conference on Monday, October 30th
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Lev Pharmaceuticals to Present at C.E. Unterberg, Towbin Life Sciences Conference on Monday, October 30th
Do you wish to request the book?
Lev Pharmaceuticals to Present at C.E. Unterberg, Towbin Life Sciences Conference on Monday, October 30th
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Newsletter
Lev Pharmaceuticals to Present at C.E. Unterberg, Towbin Life Sciences Conference on Monday, October 30th
2006
Overview
Legal notice to investors: Certain matters discussed in this news release are \"forward-looking statements.\" These forward-looking statements, which apply only on the date of this release, generally can be identified by the use of forward-looking terminology such as \"may,\" \"will,\" \"expects,\" \"intends,\" \"estimates,\" \"anticipates,\" \"believes,\" \"continues\" or words of similar import. Similarly, statements that describe [Lev]'s future plans, objectives or goals are also forward-looking statements, which generally involve known and unknown risks, uncertainties and other facts that may cause the actual results, performance or achievements of Lev to be materially different from those expressed or implied by such forward-looking statements. Drug discovery and development involve a high degree of risk.
Publisher
Business Wire
Subject
